These results indicate that PAAD patients with high expression of IFI27 are more inclined to have pancreatic adenocarcinoma that are more advanced in histologic grade, T stage, N stage and tumor stage compared to those with low levels of IFI27. This evidence concerns the gene IFI27 and neoplasm.